| Symbol |
Name |
Standardized Value |
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
3.909
|
|
TAC1
|
tachykinin, precursor 1
|
3.822
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
3.59
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
3.349
|
|
KNG1
|
kininogen 1
|
3.284
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
3.266
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
3.248
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
3.246
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
3.205
|
|
MRGPRD
|
MAS-related GPR, member D
|
3.167
|
|
SCN11A
|
sodium channel, voltage gated, type XI alpha subunit
|
3.03
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
2.828
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
2.775
|
|
ANK1
|
ankyrin 1, erythrocytic
|
2.758
|
|
PIEZO2
|
piezo-type mechanosensitive ion channel component 2
|
2.751
|
|
ASIC3
|
acid sensing (proton gated) ion channel 3
|
2.748
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
2.746
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
2.715
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
2.65
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
2.646
|
|
OPRM1
|
opioid receptor, mu 1
|
2.633
|
|
BDNF
|
brain-derived neurotrophic factor
|
2.603
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
2.596
|
|
SCN3A
|
sodium channel, voltage gated, type III alpha subunit
|
2.571
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
2.569
|
|
GALP
|
galanin-like peptide
|
2.554
|
|
GFRA3
|
GDNF family receptor alpha 3
|
2.529
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
2.523
|
|
CALCB
|
calcitonin-related polypeptide beta
|
2.509
|
|
GDNF
|
glial cell derived neurotrophic factor
|
2.493
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
2.488
|
|
IL1B
|
interleukin 1, beta
|
2.481
|
|
GRPR
|
gastrin-releasing peptide receptor
|
2.479
|
|
IL31
|
interleukin 31
|
2.478
|
|
CPAMD8
|
C3 and PZP-like, alpha-2-macroglobulin domain containing 8
|
2.462
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
2.459
|
|
DHX34
|
DEAH (Asp-Glu-Ala-His) box polypeptide 34
|
2.452
|
|
PDYN
|
prodynorphin
|
2.452
|
|
NPY
|
neuropeptide Y
|
2.451
|
|
KCNK4
|
potassium channel, two pore domain subfamily K, member 4
|
2.424
|
|
IL6
|
interleukin 6
|
2.41
|
|
PRKCG
|
protein kinase C, gamma
|
2.392
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
2.379
|
|
RARS1
|
arginyl-tRNA synthetase 1
|
2.376
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
2.369
|
|
TACR2
|
tachykinin receptor 2
|
2.363
|
|
UCMA
|
upper zone of growth plate and cartilage matrix associated
|
2.356
|
|
ARTN
|
artemin
|
2.339
|
|
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3
|
2.336
|
|
SST
|
somatostatin
|
2.335
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
2.334
|
|
TNF
|
tumor necrosis factor
|
2.328
|
|
CALCRL
|
calcitonin receptor-like
|
2.304
|
|
TAFA4
|
TAFA chemokine like family member 4
|
2.287
|
|
PNOC
|
prepronociceptin
|
2.285
|
|
KCNK18
|
potassium channel, two pore domain subfamily K, member 18
|
2.272
|
|
KCNK10
|
potassium channel, two pore domain subfamily K, member 10
|
2.27
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
2.268
|
|
GFRA2
|
GDNF family receptor alpha 2
|
2.267
|
|
IL31RA
|
interleukin 31 receptor A
|
2.267
|
|
SLC17A8
|
solute carrier family 17 (vesicular glutamate transporter), member 8
|
2.256
|
|
POMC
|
proopiomelanocortin
|
2.216
|
|
SLC17A6
|
solute carrier family 17 (vesicular glutamate transporter), member 6
|
2.207
|
|
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit
|
2.2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
2.186
|
|
PRDM12
|
PR domain containing 12
|
2.168
|
|
AVIL
|
advillin
|
2.162
|
|
ASIC2
|
acid sensing (proton gated) ion channel 2
|
2.159
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
2.132
|
|
ATF3
|
activating transcription factor 3
|
2.118
|
|
TH
|
tyrosine hydroxylase
|
2.117
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
2.115
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
2.114
|
|
TAC3
|
tachykinin 3
|
2.107
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
2.085
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
2.078
|
|
NTF3
|
neurotrophin 3
|
2.077
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
2.071
|
|
TRPC7
|
transient receptor potential cation channel, subfamily C, member 7
|
2.068
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
2.066
|
|
NGFR
|
nerve growth factor receptor
|
2.064
|
|
LNP1
|
leukemia NUP98 fusion partner 1
|
2.06
|
|
NTF4
|
neurotrophin 4
|
2.058
|
|
EDN1
|
endothelin 1
|
2.054
|
|
MRGPRX1
|
MAS-related GPR, member X1
|
2.046
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
2.018
|
|
BHLHE22
|
basic helix-loop-helix family, member e22
|
2.012
|
|
PENK
|
proenkephalin
|
2.004
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
2.004
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
2.002
|
|
KRT76
|
keratin 76, type II
|
2.001
|
|
HRH4
|
histamine receptor H4
|
1.992
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
1.989
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
1.987
|
|
IL10
|
interleukin 10
|
1.986
|
|
HTR1D
|
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
|
1.981
|
|
LIPN
|
lipase, family member N
|
1.975
|
|
TSLP
|
thymic stromal lymphopoietin
|
1.967
|
|
FBF1
|
Fas (TNFRSF6) binding factor 1
|
1.958
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
1.953
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
1.952
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
1.948
|
|
RBFOX3
|
RNA binding protein, fox-1 homolog (C. elegans) 3
|
1.947
|
|
KCNA4
|
potassium channel, voltage gated shaker related subfamily A, member 4
|
1.942
|
|
INS
|
insulin
|
1.939
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
1.931
|
|
AIF1
|
allograft inflammatory factor 1
|
1.929
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
1.925
|
|
IL4
|
interleukin 4
|
1.925
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
1.924
|
|
GFRA1
|
GDNF family receptor alpha 1
|
1.924
|
|
NAV1
|
neuron navigator 1
|
1.924
|
|
IL1A
|
interleukin 1, alpha
|
1.909
|
|
CRH
|
corticotropin releasing hormone
|
1.907
|
|
NEFH
|
neurofilament, heavy polypeptide
|
1.901
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.894
|
|
PVALB
|
parvalbumin
|
1.891
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
1.882
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
1.869
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
1.867
|
|
HRH3
|
histamine receptor H3
|
1.861
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
1.859
|
|
ACE
|
angiotensin I converting enzyme
|
1.857
|
|
KCNS1
|
potassium voltage-gated channel, modifier subfamily S, member 1
|
1.855
|
|
PXDNL
|
peroxidasin-like
|
1.846
|
|
PXDN
|
peroxidasin
|
1.845
|
|
PIRT
|
phosphoinositide-interacting regulator of transient receptor potential channels
|
1.844
|
|
ENTHD1
|
ENTH domain containing 1
|
1.843
|
|
NRTN
|
neurturin
|
1.842
|
|
IL13
|
interleukin 13
|
1.841
|
|
NTS
|
neurotensin
|
1.84
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
1.839
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
1.833
|
|
KCNA2
|
potassium channel, voltage gated shaker related subfamily A, member 2
|
1.82
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
1.819
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
1.818
|
|
TLR4
|
toll-like receptor 4
|
1.818
|
|
NPY1R
|
neuropeptide Y receptor Y1
|
1.815
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
1.815
|
|
MRGPRX2
|
MAS-related GPR, member X2
|
1.803
|
|
NANOS1
|
nanos homolog 1 (Drosophila)
|
1.787
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
1.787
|
|
GFAP
|
glial fibrillary acidic protein
|
1.786
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
1.783
|
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7
|
1.779
|
|
LEP
|
leptin
|
1.776
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
1.775
|
|
OSMR
|
oncostatin M receptor
|
1.77
|
|
FA2H
|
fatty acid 2-hydroxylase
|
1.768
|
|
ASIC4
|
acid sensing (proton gated) ion channel family member 4
|
1.758
|
|
TACR3
|
tachykinin receptor 3
|
1.757
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
1.749
|
|
IL17F
|
interleukin 17F
|
1.738
|
|
EPRS1
|
glutamyl-prolyl-tRNA synthetase 1
|
1.735
|
|
KCND1
|
potassium channel, voltage gated Shal related subfamily D, member 1
|
1.734
|
|
KCNQ5
|
potassium channel, voltage gated KQT-like subfamily Q, member 5
|
1.734
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
1.732
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
1.731
|
|
TLX3
|
T-cell leukemia homeobox 3
|
1.729
|
|
TPRA1
|
transmembrane protein, adipocyte asscociated 1
|
1.725
|
|
GAP43
|
growth associated protein 43
|
1.724
|
|
CNTNAP1
|
contactin associated protein 1
|
1.715
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
1.714
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
1.712
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
1.711
|
|
CREB1
|
cAMP responsive element binding protein 1
|
1.704
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
1.698
|
|
IFNG
|
interferon, gamma
|
1.695
|
|
KCNC4
|
potassium channel, voltage gated Shaw related subfamily C, member 4
|
1.693
|
|
IL5
|
interleukin 5
|
1.691
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
1.69
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
1.686
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
1.684
|
|
OXTR
|
oxytocin receptor
|
1.684
|
|
ADM
|
adrenomedullin
|
1.682
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
1.679
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
1.679
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
1.675
|
|
SLC6A5
|
solute carrier family 6 (neurotransmitter transporter), member 5
|
1.67
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
1.669
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
1.657
|
|
POTEF
|
POTE ankyrin domain family, member F
|
1.644
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.643
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
1.641
|
|
NMBR
|
neuromedin B receptor
|
1.64
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
1.636
|
|
MMP12
|
matrix metallopeptidase 12
|
1.633
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
1.628
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.621
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
1.618
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
1.618
|
|
SLC32A1
|
solute carrier family 32 (GABA vesicular transporter), member 1
|
1.614
|
|
BDKRB2
|
bradykinin receptor B2
|
1.613
|
|
RET
|
ret proto-oncogene
|
1.604
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
1.603
|
|
IAPP
|
islet amyloid polypeptide
|
1.603
|
|
STOML3
|
stomatin (EPB72)-like 3
|
1.602
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
1.602
|
|
ADORA1
|
adenosine A1 receptor
|
1.601
|
|
GALR2
|
galanin receptor 2
|
1.601
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
1.601
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
1.6
|
|
NRG1
|
neuregulin 1
|
1.589
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
1.589
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
1.589
|
|
IL33
|
interleukin 33
|
1.588
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
1.586
|
|
PCDHA4
|
protocadherin alpha 4
|
1.584
|
|
JUN
|
jun proto-oncogene
|
1.579
|
|
NAT8
|
N-acetyltransferase 8 (GCN5-related, putative)
|
1.578
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
1.575
|
|
HTR1F
|
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled
|
1.571
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.567
|
|
KCNK1
|
potassium channel, two pore domain subfamily K, member 1
|
1.562
|
|
HRH2
|
histamine receptor H2
|
1.556
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
1.554
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
1.553
|
|
IL2
|
interleukin 2
|
1.552
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
1.55
|
|
TMEM100
|
transmembrane protein 100
|
1.546
|
|
SCG2
|
secretogranin II
|
1.541
|
|
NPPB
|
natriuretic peptide B
|
1.54
|
|
CCKAR
|
cholecystokinin A receptor
|
1.539
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.531
|
|
SH2D3C
|
SH2 domain containing 3C
|
1.53
|
|
GALR1
|
galanin receptor 1
|
1.53
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
1.53
|
|
P2RY4
|
pyrimidinergic receptor P2Y, G-protein coupled, 4
|
1.529
|
|
UCN3
|
urocortin 3
|
1.526
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
1.525
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
1.515
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
1.512
|
|
CD4
|
CD4 molecule
|
1.508
|
|
CRLF2
|
cytokine receptor-like factor 2
|
1.508
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
1.507
|
|
NPFF
|
neuropeptide FF-amide peptide precursor
|
1.506
|
|
GPR55
|
G protein-coupled receptor 55
|
1.505
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
1.502
|
|
IL18
|
interleukin 18
|
1.497
|
|
GPR65
|
G protein-coupled receptor 65
|
1.49
|
|
COMT
|
catechol-O-methyltransferase
|
1.49
|
|
CALML4
|
calmodulin-like 4
|
1.49
|
|
PANX1
|
pannexin 1
|
1.49
|
|
CALML5
|
calmodulin-like 5
|
1.489
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.489
|
|
EDNRB
|
endothelin receptor type B
|
1.488
|
|
CALML6
|
calmodulin-like 6
|
1.486
|
|
CALML3
|
calmodulin-like 3
|
1.485
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.482
|
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1
|
1.48
|
|
EDNRA
|
endothelin receptor type A
|
1.476
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
1.476
|
|
KCNC1
|
potassium channel, voltage gated Shaw related subfamily C, member 1
|
1.471
|
|
GLRA3
|
glycine receptor, alpha 3
|
1.47
|
|
KCTD11
|
potassium channel tetramerization domain containing 11
|
1.469
|
|
RAMP3
|
receptor (G protein-coupled) activity modifying protein 3
|
1.467
|
|
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2
|
1.467
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
1.464
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.46
|
|
TMEM150C
|
transmembrane protein 150C
|
1.453
|
|
PAX2
|
paired box 2
|
1.453
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
1.452
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
1.45
|
|
GRIK1
|
glutamate receptor, ionotropic, kainate 1
|
1.448
|
|
POU4F1
|
POU class 4 homeobox 1
|
1.441
|
|
GCG
|
glucagon
|
1.44
|
|
TRPM5
|
transient receptor potential cation channel, subfamily M, member 5
|
1.438
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
1.435
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.435
|
|
SCT
|
secretin
|
1.433
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
1.433
|
|
TAFA1
|
TAFA chemokine like family member 1
|
1.432
|
|
CALB2
|
calbindin 2
|
1.43
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.427
|
|
ADM2
|
adrenomedullin 2
|
1.422
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
1.419
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
1.419
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
1.418
|
|
EPHB1
|
EPH receptor B1
|
1.417
|
|
GRIA4
|
glutamate receptor, ionotropic, AMPA 4
|
1.416
|
|
NPR1
|
natriuretic peptide receptor 1
|
1.416
|
|
TAC4
|
tachykinin 4 (hemokinin)
|
1.413
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
1.413
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
1.412
|
|
ADRB3
|
adrenoceptor beta 3
|
1.408
|
|
CMA1
|
chymase 1, mast cell
|
1.405
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
1.402
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
1.401
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
1.387
|
|
TRPM1
|
transient receptor potential cation channel, subfamily M, member 1
|
1.386
|
|
GAST
|
gastrin
|
1.386
|
|
SLC18A3
|
solute carrier family 18 (vesicular acetylcholine transporter), member 3
|
1.385
|
|
KCNA6
|
potassium channel, voltage gated shaker related subfamily A, member 6
|
1.385
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
1.38
|
|
GALR3
|
galanin receptor 3
|
1.378
|
|
CPZ
|
carboxypeptidase Z
|
1.377
|
|
PHOX2B
|
paired-like homeobox 2b
|
1.375
|
|
PYY
|
peptide YY
|
1.374
|
|
RUNX1
|
runt-related transcription factor 1
|
1.373
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.369
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.369
|
|
MMP9
|
matrix metallopeptidase 9
|
1.368
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.363
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
1.362
|
|
S100B
|
S100 calcium binding protein B
|
1.362
|
|
NANOS3
|
nanos homolog 3 (Drosophila)
|
1.359
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.359
|
|
MDFIC2
|
MyoD family inhibitor domain containing 2
|
1.356
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
1.354
|
|
LOX
|
lysyl oxidase
|
1.351
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.35
|
|
KCNB1
|
potassium channel, voltage gated Shab related subfamily B, member 1
|
1.349
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
1.347
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.346
|
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
1.346
|
|
GRM4
|
glutamate receptor, metabotropic 4
|
1.346
|
|
GRIN2D
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D
|
1.346
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
1.339
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
1.339
|
|
CAV3
|
caveolin 3
|
1.338
|
|
BDKRB1
|
bradykinin receptor B1
|
1.338
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
1.337
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
1.337
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
1.335
|
|
GPRIN1
|
G protein regulated inducer of neurite outgrowth 1
|
1.332
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
1.329
|
|
EFNB1
|
ephrin-B1
|
1.329
|
|
PTH2R
|
parathyroid hormone 2 receptor
|
1.328
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.328
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
1.327
|
|
CLSTN1
|
calsyntenin 1
|
1.327
|
|
CALB1
|
calbindin 1, 28kDa
|
1.321
|
|
ARRB2
|
arrestin, beta 2
|
1.319
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.315
|
|
TMEM233
|
transmembrane protein 233
|
1.315
|
|
CD8A
|
CD8a molecule
|
1.313
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.31
|
|
LAPTM4A
|
lysosomal protein transmembrane 4 alpha
|
1.309
|
|
CAV2
|
caveolin 2
|
1.3
|
|
P2RY14
|
purinergic receptor P2Y, G-protein coupled, 14
|
1.299
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
1.299
|
|
MPZL1
|
myelin protein zero-like 1
|
1.298
|
|
MGLL
|
monoglyceride lipase
|
1.298
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
1.292
|
|
KCNK16
|
potassium channel, two pore domain subfamily K, member 16
|
1.291
|
|
NMU
|
neuromedin U
|
1.291
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
1.291
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
1.289
|
|
ADORA2A
|
adenosine A2a receptor
|
1.289
|
|
CALCR
|
calcitonin receptor
|
1.288
|
|
SCN4B
|
sodium channel, voltage gated, type IV beta subunit
|
1.287
|
|
NF1
|
neurofibromin 1
|
1.283
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.283
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
1.282
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.282
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
1.281
|
|
TMEM120A
|
transmembrane protein 120A
|
1.28
|
|
ARRB1
|
arrestin, beta 1
|
1.277
|
|
COPS3
|
COP9 signalosome subunit 3
|
1.276
|
|
KCNK5
|
potassium channel, two pore domain subfamily K, member 5
|
1.275
|
|
CNTNAP2
|
contactin associated protein-like 2
|
1.272
|
|
AMH
|
anti-Mullerian hormone
|
1.27
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
1.268
|
|
PCDHA6
|
protocadherin alpha 6
|
1.267
|
|
TLR2
|
toll-like receptor 2
|
1.267
|
|
NEUROG2
|
neurogenin 2
|
1.266
|
|
RIC8B
|
RIC8 guanine nucleotide exchange factor B
|
1.265
|
|
GRIN2C
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2C
|
1.264
|
|
SP9
|
Sp9 transcription factor
|
1.263
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
1.263
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
1.26
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
1.258
|
|
LPAR5
|
lysophosphatidic acid receptor 5
|
1.256
|
|
TLR7
|
toll-like receptor 7
|
1.256
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
1.256
|
|
EGF
|
epidermal growth factor
|
1.255
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
1.254
|
|
MAG
|
myelin associated glycoprotein
|
1.254
|
|
PSPN
|
persephin
|
1.254
|
|
HTR3B
|
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic
|
1.253
|
|
CD68
|
CD68 molecule
|
1.252
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
1.248
|
|
P2RX6
|
purinergic receptor P2X, ligand gated ion channel, 6
|
1.247
|
|
CNTF
|
ciliary neurotrophic factor
|
1.245
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
1.244
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
1.242
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
1.238
|
|
TTR
|
transthyretin
|
1.236
|
|
NEUROG1
|
neurogenin 1
|
1.232
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.232
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
1.229
|
|
LTB4R
|
leukotriene B4 receptor
|
1.229
|
|
SYP
|
synaptophysin
|
1.228
|
|
TLR5
|
toll-like receptor 5
|
1.228
|
|
IL22
|
interleukin 22
|
1.224
|
|
CDK5
|
cyclin-dependent kinase 5
|
1.223
|
|
MAPK13
|
mitogen-activated protein kinase 13
|
1.221
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
1.22
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
1.219
|
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit
|
1.219
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
1.218
|
|
CTSS
|
cathepsin S
|
1.217
|
|
IL4R
|
interleukin 4 receptor
|
1.217
|
|
LEPROT
|
leptin receptor overlapping transcript
|
1.214
|
|
EFNB2
|
ephrin-B2
|
1.213
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.212
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
1.211
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.209
|
|
KCNV1
|
potassium channel, voltage gated modifier subfamily V, member 1
|
1.208
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
1.203
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
1.202
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.198
|
|
CMKLR1
|
chemerin chemokine-like receptor 1
|
1.198
|
|
EGR2
|
early growth response 2
|
1.197
|
|
FLG
|
filaggrin
|
1.197
|
|
GRIK5
|
glutamate receptor, ionotropic, kainate 5
|
1.196
|
|
CRCP
|
CGRP receptor component
|
1.195
|
|
P2RY13
|
purinergic receptor P2Y, G-protein coupled, 13
|
1.194
|
|
RHOD
|
ras homolog family member D
|
1.194
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.191
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
1.188
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
1.187
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
1.186
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
1.185
|
|
PPAN-P2RY11
|
PPAN-P2RY11 readthrough
|
1.181
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.181
|
|
SORD
|
sorbitol dehydrogenase
|
1.18
|
|
GRK2
|
G protein-coupled receptor kinase 2
|
1.172
|
|
PTGES
|
prostaglandin E synthase
|
1.171
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
1.17
|
|
FLG2
|
filaggrin family member 2
|
1.167
|
|
GRIK3
|
glutamate receptor, ionotropic, kainate 3
|
1.167
|
|
EDN3
|
endothelin 3
|
1.162
|
|
GPHN
|
gephyrin
|
1.16
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
1.159
|
|
PRL
|
prolactin
|
1.157
|
|
TMEM45B
|
transmembrane protein 45B
|
1.156
|
|
SCG3
|
secretogranin III
|
1.156
|
|
SCN3B
|
sodium channel, voltage gated, type III beta subunit
|
1.155
|
|
NF2
|
neurofibromin 2 (merlin)
|
1.154
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
1.152
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
1.151
|
|
CCM2
|
cerebral cavernous malformation 2
|
1.151
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
1.149
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
1.148
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
1.148
|
|
RHOA
|
ras homolog family member A
|
1.146
|
|
GPSM2
|
G-protein signaling modulator 2
|
1.142
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
1.14
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
1.139
|
|
NEFL
|
neurofilament, light polypeptide
|
1.138
|
|
NMUR1
|
neuromedin U receptor 1
|
1.138
|
|
PKD2L1
|
polycystic kidney disease 2-like 1
|
1.138
|
|
KARS1
|
lysyl-tRNA synthetase 1
|
1.138
|
|
KCNT1
|
potassium channel, sodium activated subfamily T, member 1
|
1.137
|
|
GPR32
|
G protein-coupled receptor 32
|
1.137
|
|
HMGB1
|
high mobility group box 1
|
1.135
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
1.132
|
|
REST
|
RE1-silencing transcription factor
|
1.131
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.13
|
|
ANK2
|
ankyrin 2, neuronal
|
1.13
|
|
GPR151
|
G protein-coupled receptor 151
|
1.13
|
|
SAA2
|
serum amyloid A2
|
1.13
|
|
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing
|
1.129
|
|
GPR68
|
G protein-coupled receptor 68
|
1.128
|
|
PROK2
|
prokineticin 2
|
1.127
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
1.125
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
1.123
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
1.121
|
|
PISD
|
phosphatidylserine decarboxylase
|
1.118
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
1.118
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
1.117
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
1.117
|
|
TUBB3
|
tubulin, beta 3 class III
|
1.115
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.115
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.112
|
|
KCNB2
|
potassium channel, voltage gated Shab related subfamily B, member 2
|
1.111
|
|
GPR18
|
G protein-coupled receptor 18
|
1.107
|
|
SYN1
|
synapsin I
|
1.107
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
1.106
|
|
ADORA3
|
adenosine A3 receptor
|
1.106
|
|
LLGL1
|
lethal giant larvae homolog 1 (Drosophila)
|
1.106
|
|
KCNK13
|
potassium channel, two pore domain subfamily K, member 13
|
1.105
|
|
GPR83
|
G protein-coupled receptor 83
|
1.105
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
1.102
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
1.102
|
|
HCN3
|
hyperpolarization activated cyclic nucleotide gated potassium channel 3
|
1.102
|
|
JAK2
|
Janus kinase 2
|
1.101
|
|
PLXND1
|
plexin D1
|
1.1
|
|
CADM1
|
cell adhesion molecule 1
|
1.1
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
1.099
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
1.099
|
|
ESR1
|
estrogen receptor 1
|
1.094
|
|
PRKCE
|
protein kinase C, epsilon
|
1.093
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
1.091
|
|
EPHB2
|
EPH receptor B2
|
1.088
|
|
GFRA4
|
GDNF family receptor alpha 4
|
1.088
|
|
SLC17A9
|
solute carrier family 17 (vesicular nucleotide transporter), member 9
|
1.086
|
|
JAK1
|
Janus kinase 1
|
1.084
|
|
GRM8
|
glutamate receptor, metabotropic 8
|
1.078
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1.076
|
|
FN1
|
fibronectin 1
|
1.076
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
1.074
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
1.073
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
1.072
|
|
EFNB3
|
ephrin-B3
|
1.07
|
|
TBPL1
|
TBP-like 1
|
1.068
|
|
ISL1
|
ISL LIM homeobox 1
|
1.067
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.067
|
|
MPO
|
myeloperoxidase
|
1.065
|
|
SCN7A
|
sodium channel, voltage gated, type VII alpha subunit
|
1.065
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
1.063
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
1.062
|
|
EGFR
|
epidermal growth factor receptor
|
1.061
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
1.055
|
|
TLR3
|
toll-like receptor 3
|
1.053
|
|
NAPEPLD
|
N-acyl phosphatidylethanolamine phospholipase D
|
1.05
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
1.05
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
1.05
|
|
GHSR
|
growth hormone secretagogue receptor
|
1.045
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.044
|
|
LOC107987479
|
cytochrome P450 2D6
|
1.044
|
|
LAP3
|
leucine aminopeptidase 3
|
1.043
|
|
EGR1
|
early growth response 1
|
1.042
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
1.04
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
1.036
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
1.029
|
|
IL6ST
|
interleukin 6 signal transducer
|
1.028
|
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1
|
1.027
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
1.026
|
|
PRX
|
periaxin
|
1.025
|
|
CNDP2
|
CNDP dipeptidase 2 (metallopeptidase M20 family)
|
1.022
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
1.022
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
1.019
|
|
RNMT
|
RNA (guanine-7-) methyltransferase
|
1.018
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
1.017
|
|
MMP3
|
matrix metallopeptidase 3
|
1.016
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
1.009
|
|
BCHE
|
butyrylcholinesterase
|
1.009
|
|
IFNA1
|
interferon, alpha 1
|
1.006
|
|
KITLG
|
KIT ligand
|
1.005
|
|
GLUL
|
glutamate-ammonia ligase
|
1.001
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.001
|
|
NUCB2
|
nucleobindin 2
|
1.001
|
|
SYNPR
|
synaptoporin
|
1.001
|
|
DPP4
|
dipeptidyl-peptidase 4
|
1.0
|
|
GRIK4
|
glutamate receptor, ionotropic, kainate 4
|
0.998
|
|
KCNC3
|
potassium channel, voltage gated Shaw related subfamily C, member 3
|
0.996
|
|
NFASC
|
neurofascin
|
0.996
|
|
THY1
|
Thy-1 cell surface antigen
|
0.994
|
|
MAOA
|
monoamine oxidase A
|
0.992
|
|
DRD2
|
dopamine receptor D2
|
0.99
|
|
SSTR2
|
somatostatin receptor 2
|
0.989
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
0.989
|
|
CCKBR
|
cholecystokinin B receptor
|
0.988
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
0.988
|
|
OPRD1
|
opioid receptor, delta 1
|
0.987
|
|
TSPO
|
translocator protein (18kDa)
|
0.987
|
|
ACRV1
|
acrosomal vesicle protein 1
|
0.984
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
0.982
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
0.977
|
|
PTRH2
|
peptidyl-tRNA hydrolase 2
|
0.975
|
|
NT5C3B
|
5'-nucleotidase, cytosolic IIIB
|
0.974
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
0.971
|
|
IL9
|
interleukin 9
|
0.971
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
0.97
|
|
FOXP2
|
forkhead box P2
|
0.969
|
|
ASIC5
|
acid sensing (proton gated) ion channel family member 5
|
0.968
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
0.965
|
|
GSTM1
|
glutathione S-transferase mu 1
|
0.961
|
|
FPR2
|
formyl peptide receptor 2
|
0.958
|
|
ACE2
|
angiotensin I converting enzyme 2
|
0.958
|
|
HMOX1
|
heme oxygenase 1
|
0.954
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
0.954
|
|
PROKR2
|
prokineticin receptor 2
|
0.951
|
|
SHOX2
|
short stature homeobox 2
|
0.945
|
|
NPPA
|
natriuretic peptide A
|
0.945
|
|
NANOS2
|
nanos homolog 2 (Drosophila)
|
0.945
|
|
KDELR2
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2
|
0.943
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
0.942
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
0.94
|
|
KYNU
|
kynureninase
|
0.94
|
|
MYD88
|
myeloid differentiation primary response 88
|
0.937
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
0.936
|
|
KLK5
|
kallikrein-related peptidase 5
|
0.933
|
|
KCNK15
|
potassium channel, two pore domain subfamily K, member 15
|
0.933
|
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4
|
0.933
|
|
LIF
|
leukemia inhibitory factor
|
0.929
|
|
STOM
|
stomatin
|
0.929
|
|
RUNX3
|
runt-related transcription factor 3
|
0.928
|
|
CLCA4
|
chloride channel accessory 4
|
0.925
|
|
PLP1
|
proteolipid protein 1
|
0.924
|
|
PCSK7
|
proprotein convertase subtilisin/kexin type 7
|
0.922
|
|
LBX1
|
ladybird homeobox 1
|
0.922
|
|
EPX
|
eosinophil peroxidase
|
0.92
|
|
PTH2
|
parathyroid hormone 2
|
0.919
|
|
ISL2
|
ISL LIM homeobox 2
|
0.918
|
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
0.918
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
0.918
|
|
UPK2
|
uroplakin 2
|
0.917
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
0.916
|
|
STAP2
|
signal transducing adaptor family member 2
|
0.916
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
0.916
|
|
PLAT
|
plasminogen activator, tissue
|
0.915
|
|
SSTR4
|
somatostatin receptor 4
|
0.914
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
0.913
|
|
CLCA2
|
chloride channel accessory 2
|
0.911
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
0.911
|
|
UCN
|
urocortin
|
0.911
|
|
MAOB
|
monoamine oxidase B
|
0.91
|
|
KCNS3
|
potassium voltage-gated channel, modifier subfamily S, member 3
|
0.909
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
0.909
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
0.908
|
|
FGF7
|
fibroblast growth factor 7
|
0.906
|
|
TNXB
|
tenascin XB
|
0.903
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
0.903
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
0.902
|
|
SCN2B
|
sodium channel, voltage gated, type II beta subunit
|
0.902
|
|
ACP3
|
acid phosphatase 3
|
0.901
|
|
KLK11
|
kallikrein-related peptidase 11
|
0.9
|
|
FGF3
|
fibroblast growth factor 3
|
0.9
|
|
DCUN1D2
|
DCN1, defective in cullin neddylation 1, domain containing 2
|
0.9
|
|
AHR
|
aryl hydrocarbon receptor
|
0.899
|
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3
|
0.899
|
|
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1
|
0.899
|
|
NMS
|
neuromedin S
|
0.898
|
|
CARTPT
|
CART prepropeptide
|
0.898
|
|
ECEL1
|
endothelin converting enzyme-like 1
|
0.898
|
|
DNTT
|
DNA nucleotidylexotransferase
|
0.895
|
|
PKD2L2
|
polycystic kidney disease 2-like 2
|
0.895
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
0.893
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
0.891
|
|
AVPR1B
|
arginine vasopressin receptor 1B
|
0.89
|
|
RYK
|
receptor-like tyrosine kinase
|
0.889
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
0.888
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
0.888
|
|
CBR1
|
carbonyl reductase 1
|
0.886
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
0.884
|
|
NTN4
|
netrin 4
|
0.883
|
|
OPN4
|
opsin 4
|
0.883
|
|
UPK3A
|
uroplakin 3A
|
0.882
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
0.882
|
|
NCAM1
|
neural cell adhesion molecule 1
|
0.881
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
0.88
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
0.879
|
|
GPR4
|
G protein-coupled receptor 4
|
0.878
|
|
KDR
|
kinase insert domain receptor
|
0.878
|
|
MRGPRX4
|
MAS-related GPR, member X4
|
0.877
|
|
NTN1
|
netrin 1
|
0.876
|
|
FGF9
|
fibroblast growth factor 9
|
0.876
|
|
NALCN
|
sodium leak channel, non selective
|
0.876
|
|
SELL
|
selectin L
|
0.876
|
|
KCNJ6
|
potassium channel, inwardly rectifying subfamily J, member 6
|
0.874
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
0.873
|
|
SYN2
|
synapsin II
|
0.873
|
|
APOE
|
apolipoprotein E
|
0.873
|
|
SELE
|
selectin E
|
0.873
|
|
TPM3
|
tropomyosin 3
|
0.872
|
|
MINDY4
|
MINDY lysine 48 deubiquitinase 4
|
0.871
|
|
SYN3
|
synapsin III
|
0.87
|
|
FGF13
|
fibroblast growth factor 13
|
0.868
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
0.867
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
0.864
|
|
AGRP
|
agouti related neuropeptide
|
0.863
|
|
GRM6
|
glutamate receptor, metabotropic 6
|
0.862
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
0.862
|
|
CREM
|
cAMP responsive element modulator
|
0.86
|
|
PPIAP39
|
peptidylprolyl isomerase A pseudogene 39
|
0.86
|
|
FGF18
|
fibroblast growth factor 18
|
0.859
|
|
LPAR4
|
lysophosphatidic acid receptor 4
|
0.857
|
|
CHRM4
|
cholinergic receptor, muscarinic 4
|
0.856
|
|
MMP2
|
matrix metallopeptidase 2
|
0.856
|
|
KCNK17
|
potassium channel, two pore domain subfamily K, member 17
|
0.856
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
0.856
|
|
SDF4
|
stromal cell derived factor 4
|
0.855
|
|
IL3
|
interleukin 3
|
0.855
|
|
KCNK7
|
potassium channel, two pore domain subfamily K, member 7
|
0.852
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
0.851
|
|
ENTPD3
|
ectonucleoside triphosphate diphosphohydrolase 3
|
0.851
|
|
TRH
|
thyrotropin-releasing hormone
|
0.85
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
0.848
|
|
APP
|
amyloid beta (A4) precursor protein
|
0.847
|
|
C5AR1
|
complement component 5a receptor 1
|
0.847
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
0.846
|
|
STIM1
|
stromal interaction molecule 1
|
0.845
|
|
PPY
|
pancreatic polypeptide
|
0.844
|
|
KCNK12
|
potassium channel, two pore domain subfamily K, member 12
|
0.844
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
0.841
|
|
GRM7
|
glutamate receptor, metabotropic 7
|
0.841
|
|
KCNIP2
|
Kv channel interacting protein 2
|
0.838
|
|
PHOX2A
|
paired-like homeobox 2a
|
0.836
|
|
EFNA5
|
ephrin-A5
|
0.835
|
|
ENTPD8
|
ectonucleoside triphosphate diphosphohydrolase 8
|
0.831
|
|
IL6R
|
interleukin 6 receptor
|
0.831
|
|
AVPR2
|
arginine vasopressin receptor 2
|
0.83
|
|
POSTN
|
periostin, osteoblast specific factor
|
0.829
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
0.827
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
0.827
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
0.826
|
|
ENTPD2
|
ectonucleoside triphosphate diphosphohydrolase 2
|
0.825
|
|
SPTLC1
|
serine palmitoyltransferase, long chain base subunit 1
|
0.825
|
|
AQP5
|
aquaporin 5
|
0.822
|
|
OCLN
|
occludin
|
0.822
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
0.821
|
|
AK1
|
adenylate kinase 1
|
0.819
|
|
AKAP5
|
A kinase (PRKA) anchor protein 5
|
0.819
|
|
ACAN
|
aggrecan
|
0.817
|
|
TRIM32
|
tripartite motif containing 32
|
0.816
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
0.814
|
|
PHF12
|
PHD finger protein 12
|
0.814
|
|
CORT
|
cortistatin
|
0.813
|
|
PRKCA
|
protein kinase C, alpha
|
0.813
|
|
GPX3
|
glutathione peroxidase 3
|
0.813
|
|
SLC6A13
|
solute carrier family 6 (neurotransmitter transporter), member 13
|
0.812
|
|
C2CD2
|
C2 calcium-dependent domain containing 2
|
0.812
|
|
DAGLA
|
diacylglycerol lipase, alpha
|
0.809
|
|
FGF6
|
fibroblast growth factor 6
|
0.806
|
|
EARS2
|
glutamyl-tRNA synthetase 2, mitochondrial
|
0.806
|
|
TGFA
|
transforming growth factor, alpha
|
0.805
|
|
NECAB2
|
N-terminal EF-hand calcium binding protein 2
|
0.805
|
|
AANAT
|
aralkylamine N-acetyltransferase
|
0.805
|
|
PRKCB
|
protein kinase C, beta
|
0.804
|
|
TMEM35A
|
transmembrane protein 35A
|
0.803
|
|
PLPPR3
|
phospholipid phosphatase related 3
|
0.802
|
|
PXMP2
|
peroxisomal membrane protein 2, 22kDa
|
0.8
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
0.8
|
|
FGF17
|
fibroblast growth factor 17
|
0.799
|
|
NAAA
|
N-acylethanolamine acid amidase
|
0.799
|
|
SPRR1A
|
small proline-rich protein 1A
|
0.798
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
0.798
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
0.797
|
|
ERLN
|
endoregulin
|
0.797
|
|
ITGAD
|
integrin, alpha D
|
0.794
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
0.794
|
|
CLCA1
|
chloride channel accessory 1
|
0.794
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
0.794
|
|
VPS18
|
vacuolar protein sorting 18 homolog (S. cerevisiae)
|
0.794
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
0.793
|
|
NCMAP
|
noncompact myelin associated protein
|
0.793
|
|
THBS4
|
thrombospondin 4
|
0.793
|
|
ADGRG6
|
adhesion G protein-coupled receptor G6
|
0.792
|
|
SCRT1
|
scratch family zinc finger 1
|
0.791
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
0.791
|
|
FGF22
|
fibroblast growth factor 22
|
0.79
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
0.79
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
0.79
|
|
NRP1
|
neuropilin 1
|
0.789
|
|
ECE1
|
endothelin converting enzyme 1
|
0.789
|
|
FGF16
|
fibroblast growth factor 16
|
0.789
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
0.788
|
|
FGF20
|
fibroblast growth factor 20
|
0.787
|
|
SARM1
|
sterile alpha and TIR motif containing 1
|
0.786
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
0.786
|
|
PLXNC1
|
plexin C1
|
0.783
|
|
SV2A
|
synaptic vesicle glycoprotein 2A
|
0.782
|
|
MMP24
|
matrix metallopeptidase 24 (membrane-inserted)
|
0.782
|
|
CACNA1F
|
calcium channel, voltage-dependent, L type, alpha 1F subunit
|
0.781
|
|
SORT1
|
sortilin 1
|
0.781
|
|
L1CAM
|
L1 cell adhesion molecule
|
0.78
|
|
OSTF1
|
osteoclast stimulating factor 1
|
0.779
|
|
CHODL
|
chondrolectin
|
0.779
|
|
GPX2
|
glutathione peroxidase 2
|
0.779
|
|
IL15
|
interleukin 15
|
0.778
|
|
FGF5
|
fibroblast growth factor 5
|
0.778
|
|
KCNN1
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1
|
0.777
|
|
FGF4
|
fibroblast growth factor 4
|
0.775
|
|
GCH1
|
GTP cyclohydrolase 1
|
0.774
|
|
ELANE
|
elastase, neutrophil expressed
|
0.774
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
0.774
|
|
PMCH
|
pro-melanin-concentrating hormone
|
0.774
|
|
TJP1
|
tight junction protein 1
|
0.774
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
0.773
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
0.773
|
|
FGF10
|
fibroblast growth factor 10
|
0.773
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
0.773
|
|
FZR1
|
fizzy/cell division cycle 20 related 1 (Drosophila)
|
0.771
|
|
EXOC1L
|
exocyst complex component 1 like
|
0.771
|
|
NECTIN1
|
nectin cell adhesion molecule 1
|
0.77
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
0.768
|
|
CKB
|
creatine kinase, brain
|
0.768
|
|
MOXD1
|
monooxygenase, DBH-like 1
|
0.766
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
0.765
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
0.764
|
|
ADRB1
|
adrenoceptor beta 1
|
0.764
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
0.763
|
|
CADM3
|
cell adhesion molecule 3
|
0.763
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
0.762
|
|
IL11
|
interleukin 11
|
0.762
|
|
GPX6
|
glutathione peroxidase 6
|
0.762
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
0.761
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
0.761
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
0.76
|
|
GPX5
|
glutathione peroxidase 5
|
0.76
|
|
GPX8
|
glutathione peroxidase 8 (putative)
|
0.76
|
|
MECP2
|
methyl CpG binding protein 2
|
0.759
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
0.758
|
|
GPX7
|
glutathione peroxidase 7
|
0.757
|
|
FXYD7
|
FXYD domain containing ion transport regulator 7
|
0.755
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
0.754
|
|
FXYD2
|
FXYD domain containing ion transport regulator 2
|
0.754
|
|
LOC124905743
|
low affinity immunoglobulin gamma Fc region receptor III-B
|
0.752
|
|
VWF
|
von Willebrand factor
|
0.751
|
|
CKM
|
creatine kinase, muscle
|
0.749
|
|
USP5
|
ubiquitin specific peptidase 5 (isopeptidase T)
|
0.749
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
0.748
|
|
EPHA1
|
EPH receptor A1
|
0.748
|
|
HDAC9
|
histone deacetylase 9
|
0.748
|
|
VAMP1
|
vesicle-associated membrane protein 1 (synaptobrevin 1)
|
0.746
|
|
CPEB3
|
cytoplasmic polyadenylation element binding protein 3
|
0.744
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
0.744
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
0.741
|
|
TLR9
|
toll-like receptor 9
|
0.741
|
|
MRLN
|
myoregulin
|
0.74
|
|
GATA3
|
GATA binding protein 3
|
0.738
|
|
AREG
|
amphiregulin
|
0.735
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
0.733
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
0.732
|
|
GSR
|
glutathione reductase
|
0.731
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
0.73
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
0.727
|
|
FUS
|
FUS RNA binding protein
|
0.724
|
|
ADA
|
adenosine deaminase
|
0.724
|
|
IL7
|
interleukin 7
|
0.723
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
0.721
|
|
MMP13
|
matrix metallopeptidase 13
|
0.721
|
|
FABP7
|
fatty acid binding protein 7, brain
|
0.719
|
|
EPHA4
|
EPH receptor A4
|
0.718
|
|
CHAMP1
|
chromosome alignment maintaining phosphoprotein 1
|
0.718
|
|
IRF8
|
interferon regulatory factor 8
|
0.718
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
0.717
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
0.717
|
|
NES
|
nestin
|
0.716
|
|
NPIPA5
|
nuclear pore complex interacting protein family, member A5
|
0.715
|
|
DRD1
|
dopamine receptor D1
|
0.714
|
|
KCNS2
|
potassium voltage-gated channel, modifier subfamily S, member 2
|
0.713
|
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box)
|
0.713
|
|
TAS1R3
|
taste receptor, type 1, member 3
|
0.713
|
|
LTK
|
leukocyte receptor tyrosine kinase
|
0.713
|
|
SELENOP
|
selenoprotein P
|
0.713
|
|
DRGX
|
dorsal root ganglia homeobox
|
0.711
|
|
AGTR1
|
angiotensin II receptor, type 1
|
0.711
|
|
TMEM119
|
transmembrane protein 119
|
0.708
|
|
TP53
|
tumor protein p53
|
0.707
|
|
SHH
|
sonic hedgehog
|
0.707
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
0.705
|
|
MCOLN1
|
mucolipin 1
|
0.703
|
|
GPR132
|
G protein-coupled receptor 132
|
0.703
|
|
SYT1
|
synaptotagmin I
|
0.702
|
|
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1
|
0.7
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
0.7
|
|
LCN2
|
lipocalin 2
|
0.697
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
0.695
|
|
GJD2
|
gap junction protein, delta 2, 36kDa
|
0.695
|
|
CNTN1
|
contactin 1
|
0.694
|
|
SPTLC2
|
serine palmitoyltransferase, long chain base subunit 2
|
0.693
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
0.693
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
0.693
|
|
VGF
|
VGF nerve growth factor inducible
|
0.69
|
|
MMP1
|
matrix metallopeptidase 1
|
0.69
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
0.69
|
|
IFNA2
|
interferon, alpha 2
|
0.69
|
|
ALKAL1
|
ALK and LTK ligand 1
|
0.69
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
0.689
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
0.688
|
|
CADM4
|
cell adhesion molecule 4
|
0.688
|
|
PIN4
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 4
|
0.687
|
|
LGI4
|
leucine-rich repeat LGI family, member 4
|
0.686
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
0.685
|
|
TAFA3
|
TAFA chemokine like family member 3
|
0.685
|
|
B2M
|
beta-2-microglobulin
|
0.682
|
|
EPHB6
|
EPH receptor B6
|
0.681
|
|
CD34
|
CD34 molecule
|
0.68
|
|
NUDT9
|
nudix (nucleoside diphosphate linked moiety X)-type motif 9
|
0.68
|
|
LOXL2
|
lysyl oxidase-like 2
|
0.679
|
|
SIRT1
|
sirtuin 1
|
0.677
|
|
CD163
|
CD163 molecule
|
0.677
|
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
0.676
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
0.676
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
0.674
|
|
ANGPT1
|
angiopoietin 1
|
0.674
|
|
KCNK6
|
potassium channel, two pore domain subfamily K, member 6
|
0.673
|
|
COPS9
|
COP9 signalosome subunit 9
|
0.673
|
|
GPR26
|
G protein-coupled receptor 26
|
0.672
|
|
ALPP
|
alkaline phosphatase, placental
|
0.67
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
0.67
|
|
PIANP
|
PILR alpha associated neural protein
|
0.67
|
|
KCNIP3
|
Kv channel interacting protein 3, calsenilin
|
0.669
|
|
HTR3C
|
5-hydroxytryptamine (serotonin) receptor 3C, ionotropic
|
0.668
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
0.666
|
|
IFNA17
|
interferon, alpha 17
|
0.664
|
|
C1D
|
C1D nuclear receptor corepressor
|
0.663
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
0.663
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
0.663
|
|
IRF5
|
interferon regulatory factor 5
|
0.662
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
0.661
|
|
C3
|
complement component 3
|
0.661
|
|
CD86
|
CD86 molecule
|
0.659
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
0.657
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
0.657
|
|
AOC1
|
amine oxidase, copper containing 1
|
0.657
|
|
CD207
|
CD207 molecule, langerin
|
0.657
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
0.655
|
|
GLRA1
|
glycine receptor, alpha 1
|
0.654
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
0.654
|
|
HOMER1
|
homer scaffolding protein 1
|
0.652
|
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
|
0.652
|
|
CCN2
|
cellular communication network factor 2
|
0.651
|
|
CPEB2
|
cytoplasmic polyadenylation element binding protein 2
|
0.65
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
0.65
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
0.65
|
|
KCNA10
|
potassium channel, voltage gated shaker related subfamily A, member 10
|
0.647
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
0.647
|
|
DBX1
|
developing brain homeobox 1
|
0.647
|
|
NPIPB11
|
nuclear pore complex interacting protein family, member B11
|
0.647
|
|
IL37
|
interleukin 37
|
0.644
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
0.643
|
|
FFAR3
|
free fatty acid receptor 3
|
0.641
|
|
GLB1
|
galactosidase, beta 1
|
0.64
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
0.64
|
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional)
|
0.64
|
|
IFNA10
|
interferon, alpha 10
|
0.64
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
0.639
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
0.638
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
0.638
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
0.637
|
|
NOX1
|
NADPH oxidase 1
|
0.636
|
|
MMP8
|
matrix metallopeptidase 8
|
0.636
|
|
CYCS
|
cytochrome c, somatic
|
0.634
|
|
PKD1L3
|
polycystic kidney disease 1-like 3
|
0.632
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
0.631
|
|
ZSCAN20
|
zinc finger and SCAN domain containing 20
|
0.631
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
0.629
|
|
GPKOW
|
G patch domain and KOW motifs
|
0.628
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
0.627
|
|
ALKAL2
|
ALK and LTK ligand 2
|
0.626
|
|
A2M
|
alpha-2-macroglobulin
|
0.625
|
|
NRCAM
|
neuronal cell adhesion molecule
|
0.624
|
|
ETV1
|
ets variant 1
|
0.624
|
|
PRKD2
|
protein kinase D2
|
0.623
|
|
ALDH18A1
|
aldehyde dehydrogenase 18 family, member A1
|
0.621
|
|
FOXP3
|
forkhead box P3
|
0.621
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
0.62
|
|
POU3F1
|
POU class 3 homeobox 1
|
0.619
|
|
MSTN
|
myostatin
|
0.616
|
|
PLXNA1
|
plexin A1
|
0.616
|
|
POU4F2
|
POU class 4 homeobox 2
|
0.615
|
|
FMR1
|
fragile X mental retardation 1
|
0.615
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
0.615
|
|
SNAP23
|
synaptosomal-associated protein, 23kDa
|
0.615
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
0.615
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
0.614
|
|
GHRH
|
growth hormone releasing hormone
|
0.614
|
|
NRN1
|
neuritin 1
|
0.614
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
0.613
|
|
PLCG1
|
phospholipase C, gamma 1
|
0.613
|
|
IL24
|
interleukin 24
|
0.612
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
0.61
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
0.61
|
|
MC4R
|
melanocortin 4 receptor
|
0.61
|
|
TECR
|
trans-2,3-enoyl-CoA reductase
|
0.61
|
|
PAX6
|
paired box 6
|
0.608
|
|
INSR
|
insulin receptor
|
0.606
|
|
CA3
|
carbonic anhydrase III
|
0.605
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
0.604
|
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1
|
0.604
|
|
IFNA16
|
interferon, alpha 16
|
0.604
|
|
PLG
|
plasminogen
|
0.604
|
|
IFNA21
|
interferon, alpha 21
|
0.603
|
|
IFNA7
|
interferon, alpha 7
|
0.603
|
|
STMN2
|
stathmin 2
|
0.603
|
|
CPEB4
|
cytoplasmic polyadenylation element binding protein 4
|
0.602
|
|
STK11
|
serine/threonine kinase 11
|
0.601
|
|
TRAPPC10
|
trafficking protein particle complex 10
|
0.601
|
|
IFNA6
|
interferon, alpha 6
|
0.601
|
|
IFNA8
|
interferon, alpha 8
|
0.601
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
0.601
|
|
IFNA14
|
interferon, alpha 14
|
0.601
|
|
KCNAB2
|
potassium channel, voltage gated subfamily A regulatory beta subunit 2
|
0.599
|
|
VEGFC
|
vascular endothelial growth factor C
|
0.598
|
|
CHGB
|
chromogranin B
|
0.598
|
|
IFNA5
|
interferon, alpha 5
|
0.598
|
|
IL17RA
|
interleukin 17 receptor A
|
0.597
|
|
HECA
|
headcase homolog (Drosophila)
|
0.597
|
|
MRC1
|
mannose receptor, C type 1
|
0.596
|
|
PAX3
|
paired box 3
|
0.596
|
|
TINAGL1
|
tubulointerstitial nephritis antigen-like 1
|
0.596
|
|
TAS1R2
|
taste receptor, type 1, member 2
|
0.595
|
|
HEYL
|
hes-related family bHLH transcription factor with YRPW motif-like
|
0.595
|
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like)
|
0.595
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
0.594
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
0.594
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
0.593
|
|
COL15A1
|
collagen, type XV, alpha 1
|
0.593
|
|
CELF6
|
CUGBP, Elav-like family member 6
|
0.593
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
0.592
|
|
IFNA13
|
interferon, alpha 13
|
0.592
|
|
CDH9
|
cadherin 9, type 2 (T1-cadherin)
|
0.591
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
0.59
|
|
KCNT2
|
potassium channel, sodium activated subfamily T, member 2
|
0.59
|
|
FLT1
|
fms-related tyrosine kinase 1
|
0.59
|
